Sales from the formulation business in India in Q1 was at Rs 1,064.3 crore over Rs 1,035.2 crore in the previous corresponding quarter, a growth of 2.8 per cent, the company said, adding, in North America, sales of finished dosage formulations clocked Rs 808.5 crore as against Rs 662.8 crore in the same period a year ago.
Sales from the formulation business in India in Q1 was at Rs 1,064.3 crore over Rs 1,035.2 crore in the previous corresponding quarter, a growth of 2.8 per cent, the company said, adding, in North America, sales of finished dosage formulations clocked Rs 808.5 crore as against Rs 662.8 crore in the same period a year ago. Sales from the formulation business in India in Q1 was at Rs 1,064.3 crore over Rs 1,035.2 crore in the previous corresponding quarter, a growth of 2.8 per cent, the company said, adding, in North America, sales of finished dosage formulations clocked Rs 808.5 crore as against Rs 662.8 crore in the same period a year ago. Moneycontrol Latest News Read More
हिन्दी 
English